Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
226M
-
Number of holders
-
1563
-
Total 13F shares, excl. options
-
205M
-
Shares change
-
+3.1M
-
Total reported value, excl. options
-
$75.7B
-
Value change
-
+$810M
-
Put/Call ratio
-
0.87
-
Number of buys
-
559
-
Number of sells
-
-1003
-
Price
-
$368.90
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2024
1,912 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q4 2024.
Elevance Health, Inc. - Common Stock (ELV) has 1,563 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 205M shares
of 226M outstanding shares and own 90.77% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (21.5M shares), BlackRock, Inc. (20.4M shares), STATE STREET CORP (10.7M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.6M shares), WELLINGTON MANAGEMENT GROUP LLP (6.36M shares), GEODE CAPITAL MANAGEMENT, LLC (4.96M shares), Sanders Capital, LLC (4.69M shares), Capital International Investors (3.88M shares), First Eagle Investment Management, LLC (3.23M shares), and NORGES BANK (3.08M shares).
This table shows the top 1563 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.